If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1988 Ph.D. (Pathology and Cell Biology), Thomas Jefferson University, Philadelphia
  • 1982 M.D., Taipei Medical College, Taipei, Taiwan

Experience

  • 2011- Professor, Taipei Medical University
  • 2017- Director, Research Center of Cancer Translational Medicine, Taipei Medical University
  • 2011-2017 President, Taipei Medical University
  • Affiliate Professor, California Institute of Technology, Pasadena, CA
  • Chair, The Chinese Oncology Society
  • Chair, ASCO International Affair Community
  • Chair, Molecular Pharmacology Department, City of Hope
  • Associate Director for Translational Research, City of Hope Comprehensive Cancer Center
  • Adjunct Professor, School of Pharmacy, University of Southern California
  • Adjunct Professor, Graduate Institute of Oncology, College of Medicine, National Taiwan University

Awards

  • Academician, International Academy of Engineering, Russia
  • Fellow, American Association for the Advancement of Science(AAAS)
  • Tang Prize Board Member
  • Board of Trustees, NHRI (Taiwan NIH), Taiwan
  • Kuong-Chi Scholar, Zhejiang University, Hangzhou, China
  • Steering Committee of Ming Hsieh Institute, USA
  • Who’s Who International and Professional Member (life member)
  • America’s Top Doctor (life member)
  • Hedvig Foundation Award
  • Cooper Portrait for Scientific Achievement Award in Cooper Auditorium, City of Hope
  • Distinguished Alumnus Award, Thomas Jefferson University, Philadelphia

Research Interests

  • Cancer Research
  • Translational Medicine

 

Fingerprint Dive into the research topics where Yun Yen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 81 Similar Profiles
Ribonucleotide Reductases Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Hydroxyurea Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2020

第3期癌症研究跨機構合作平台及其整合應用(第2年)

Yen, Y.

1/1/1912/1/19

Project: A - Government Institutionc - Ministry of Health and Welfare

2-1 發展特色研究,推動轉譯醫學-癌症轉譯研究中心業務費

Yen, Y.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

108年度高等教育深耕計畫第2部分-特色領域研究中心計畫

Yen, Y.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

21121 發展特色研究邁向國際級研究中心-轉譯創新整合研究計畫癌症轉譯領域計畫經費

Yen, Y.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

Research Output 1994 2019

Open Access
temozolomide
Glioblastoma
Phenotype
Glioma
Stem Cells

Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost

Kuo, C. N., Liao, Y. M., Kuo, L. N., Tsai, H. J., Chang, W. C. & Yen, Y., Jan 1 2019, (Accepted/In press) In : Journal of the Formosan Medical Association.

Research output: Contribution to journalReview article

Open Access
Taiwan
Health Care Costs
Epidemiology
Biomarkers
Therapeutic Uses

Chicken-Derived Humanized Antibody Targeting a Novel Epitope F2pep of Fibroblast Growth Factor Receptor 2: Potential Cancer Therapeutic Agent

Tsai, K. C., Chang, C. D., Cheng, M. H., Lin, T. Y., Lo, Y. N., Yang, T. W., Chang, F. L., Chiang, C. W., Lee, Y. C. & Yen, Y., Jan 31 2019, In : ACS Omega. 4, 1, p. 2387-2397 11 p.

Research output: Contribution to journalArticle

Open Access
Receptor, Fibroblast Growth Factor, Type 2
Epitopes
Antibodies, Monoclonal, Humanized
Fibroblast Growth Factor Receptors
Fibroblasts

Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma

Madamsetty, V. S., Pal, K., Dutta, S. K., Wang, E., Thompson, J. R., Banerjee, R. K., Caulfield, T. R., Mody, K., Yen, Y., Mukhopadhyay, D. & Huang, H-S., Oct 4 2019, In : Bioconjugate Chemistry.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
gemcitabine
Adenocarcinoma
Chemotherapy
Protein-Tyrosine Kinases
1 Citation (Scopus)

DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)

Chen, C. W., Li, Y., Hu, S., Zhou, W., Meng, Y., Li, Z., Zhang, Y., Sun, J., Bo, Z., DePamphilis, M. L., Yen, Y., Han, Z. & Zhu, W., Mar 2019, In : Oncogene.

Research output: Contribution to journalArticle

Ribonucleotide Reductases
DNA Replication
gemcitabine
Growth
Deoxyribonucleosides